Decomplix regulatory affairs team in a workshop at sitem-insel Bern with hybrid video conferencing

Medical device regulatory strategy and gap analyses

The right strategy for faster and safer market access.

 

Get a solid starting position that saves you time and money in your project.

Anyone who develops and wants to sell a medical device must make a careful decision about the target markets. In addition to commercial decision criteria, such as revenue and market share, regulatory requirements are also decisively important. Not taking these into account may result in exploding costs and timelines in product development — the product may not reach the market at all. Therefore, it absolutely pays to set a regulatory strategy in advance.

Decomplix’ medical device regulatory strategy and gap analyses service includes:

  • We provide strategic plans including estimated timelines and costs to choose the most efficient regulatory pathway to CE mark.

  • We elaborate regulatory options and their implications, in consideration of your product’s intended features/claims.

  • We identify potential compliance show-stoppers in your project.

 
  • We evaluate whether you need to perform a clinical study for your CE marking, one of the most expensive and time consuming activities on the way to market.

  • We help you design a compliant supply chain for placing on the market CE-marked products.

  • We review your intended labeling/claims and deliver relevant proposals to balance compliance and marketing expectations.

To shorten your time to market, we offer expert opinions, specific input with rapid feedback that saves you time in your project and ensures that you are heading in the right direction.
Our support can be structured in a modular manner to suit your needs at your own pace. In our offer, an experienced Regulatory Affairs professional performs a regulatory evaluation of your existing documentation and processes to identify applicable requirements, confirm device qualification/classification, clarify further questions, and check what to consider for the regulatory strategy.

Set up your regulatory strategy as early as possible

There are several factors to consider when deciding which market to enter with a medical device. Market strategy should not be established without regulatory considerations, and should not be only driven by economic factors like revenue and market share. The attractiveness of a market needs to be weighed with regulatory requirements in mind as the time, cost, and complexity of getting and maintaining a medical device approval cannot be underestimated.

The regulatory strategy should be set up in the early phases of the product development process, as it impacts the market launch, marketing activities, and therefore the business. Moreover, under the EU MDR and IVDR, a strategy for regulatory compliance is a requirement of the manufacturer’s Quality Management System (QMS) and it must include compliance with conformity assessment procedures and those for management of modifications to the devices.
For more information, see our blog article Medical device regulatory strategy – US vs. EU.

Your regulatory strategy is intertwined with your marketing strategy, as gaining access to markets is preceded by regulatory approval. To anticipate the time, cost, and complexity of getting your device approved in a particular market, you (obviously) need to know the regulatory requirements applicable to your device.

Decomplix CEO Beni Hirt in a regulatory consulting meeting with clients at sitem-insel Bern

Set up your regulatory strategy as early as possible.

In almost all markets worldwide, the risk classification determines the regulatory pathway and, therefore, the level of regulatory scrutiny that applies to your device. To classify your device, you need to have defined its intended purpose and intended user as well as a list of planned device functions. Therefore, a regulatory strategy can only be developed once the preliminary user requirements and outline of product functionality are available.

The regulatory pathway is the cornerstone of your regulatory strategy and, for CE marking, this entails at least an initial opinion on the classification of the device, which in turns determines the conformity assessment route required and whether or not a Notified Body needs to be involved.

Contact us

Portrait of Helena Lacalle

Helena Lacalle
Regulatory Affairs Director

Helena Lacalle is a Regulatory Affairs professional with over 20 years of experience in strictly regulated fields like medical devices and pharmaceuticals. Helena Lacalle holds a pharmacist degree from the University of Barcelona, a Master degree in Statistics from the University of Neuchatel, Switzerland, and has strong language skills in English, French, and Spanish. With her extensive regulatory expertise, she supports Decomplix’ customers both on strategic levels and on detailed regulatory questions.

Why Decomplix as your partner

  • 100+ medical device and in-vitro diagnostic companies of all shapes and sizes trust Decomplix — from startups to corporates, from Switzerland to all around the globe.

  • Decomplix’ high level of compliance and regulatory knowledge was confirmed by a successful Swissmedic inspection in 2022. Decomplix is one of the few inspected CH-REPs without any non-conformities.

  • Decomplix’ customers benefit from easy-to-use digital tools with secure and compliant IT infrastructure.

  • Decomplix stands by as a coach in compliance matters and as the customer’s close contact to Swiss authorities.

Nicolas Höfler
Nicolas HöflerGroupe Mutuel, Switzerland
«Decomplix gives us the necessary security in the use of software as a medical device during digitalization.»
Dr. Corina Matzdorf
Dr. Corina Matzdorfulrich GmbH & Co. KG, Germany
«Being a German high-quality manufacturer for medical devices with more than 110 years of experience and operating worldwide, we feel very safe with Decomplix.»
Renate Reiss
Renate ReissNeoNavia GmbH, Germany
«Due to service quality, regulatory knowledge, and reliability, we can highly recommend Decomplix as CH-REP.»
Manuel Baumann
Manuel BaumannOviva AG, Switzerland
«We benefited tremendously from Decomplix's experience and expertise in working with the Swiss authority, Swissmedic, and with Notified Bodies.»
Benjamin Schlenker
Benjamin SchlenkerCanvys – Visual Technology Solutions, Germany
«With Decomplix as our CH-REP and partner, we feel well-supported. The collaboration is exceptionally professional and efficient.»
Teija Ålander
Teija ÅlanderOrkla – Wound Care, Sweden
«We are very satisfied with the support and helpful knowledge of Decomplix as CH-REP.»
Susanne Vesterinen
Susanne VesterinenRFSU AB, Sweden
«It feels very good to have Decomplix as CH-REP.»
Florian Schulz
Florian SchulzOBERON GmbH Fiber Technologies, Germany
«Decomplix offers a professional approach and streamlined process for compliance and specific requirements of the Swiss market.»
Claudia Handler
Claudia HandlerCARE diagnostica, Austria
«We appreciate the clear procedure, the professional approach, and the uncomplicated cooperation and highly recommend Decomplix as a business partner.»
Jonas Widmer
Jonas WidmerBalgrist University Hospital, Switzerland
«With the regulatory evaluation of our planning software, we were able to take key steps in product development with Decomplix.»
Eric Tscharner
Eric TscharnerHASA OPTIX, Belgium
«As a premium manufacturer of ophthalmic instruments, we feel very secure with Decomplix.»
Dominik Gutzler
Dominik GutzlerCytoSorbents Europe GmbH, Germany
«Decomplix as CH-REP is our partner of choice, providing us with a great comprehensive service and allowing us to focus our internal resources on other projects.»
Sang-Il Kim
Sang-Il KimFederal Office of Public Health FOPH, Switzerland
«Decomplix has done an excellent job for the SwissCovid App while working under high pressure. The team is reliable, fast and extremely competent.»
Alain Kamm
Alain KammSanitas Health Insurance, Switzerland
«For our digital health initiatives, we feel we are in safe hands with Decomplix.»
Thomas Farner
Thomas FarnerAxon Lab AG, Switzerland
«Thanks to Decomplix' great expertise, pragmatic approach and support, we were ready for the CH requirements for IVD/MD importers and CH-REPs within a short time.»
Runa Emura
Runa EmuraKonan Medical Inc., Japan
«Decomplix quickly provides us with new and updated information on medical devices in Switzerland. We are very satisfied with their service.»
José Näf
José Näfnahtlos GmbH, Switzerland
«Decomplix' Regulatory Support helps us quick and uncomplicated — I can thoroughly recommend it to any medical start-up.»
Matías Hosiasson
Matías HosiassonBiomedical Devices SpA, Chile
«Decomplix took a pragmatic approach and enabled us to make an informed decision on the regulatory pathway.»
Hemera Beretta
Hemera BerettaNeuroPro AG, Switzerland
«Decomplix provided valuable expertise for understanding the regulatory framework of medical device, data protection and IT security.»
Pascal Reichmuth
Pascal ReichmuthRikai AG, Switzerland
«Thanks to the comprehensive strategy workshop with Decomplix, we understand how to classify and develop our product Rikai as medical device software.»
Markus Piller
Markus PillerMedid AG, Switzerland
«The flexibility, broad-based expertise and the will to always find a suitable solution for our problems as a small MedTech company are qualities we greatly appreciate about Decomplix.»

Choose CE marking services that match your needs

Glass facade of the sitem-insel innovation centre in Bern, home of Decomplix AG

Medical software of Health Insurers

Compliant solutions for regulatory challenges with medical software.

Five professionals gathered around a conference table reviewing documents and a laptop in a bright office building

Transition from IVDD to IVDR (in vitro diagnostics)

We support you in implementing the new regulatory requirements on time and in a structured way.

Group of professionals in a meeting seen through a glass-walled conference room

CE marking of in-vitro diagnostic medical devices (IVDs)

Overcome regulatory hurdles more efficiently and securely with us.

Four colleagues collaborating around a table with laptops in a modern office

CE-certified medical device software

Transform your algorithm into a CE-certified medical device software in less than a year.

Decomplix regulatory affairs team in a meeting at the sitem-insel Bern innovation campus

Technical documentation for medical devices

Make your technical documentation compliant with tailored gap analyses, rapid feedback and compilation support.

Latest from our blog